NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

"We could do the same thing Northwest Bio, Tocagen, Selbach, or any of these companies that have already done trials do.

But at the end of the day, it doesn’t really cure GBM unless there’s something a little bit broader."

Wow, that's quite a quote to use as an example of LL actually mentioning NWBO in the last couple of years. In the one reference you could find she states that NWBO's trial isn't the answer to curing GBM. Just amazing. Great find! What you posted 100-percent supports my theory that she has moved on from NWBO. She is done with them. And from what I have gleaned it seems the relationship today is rather frosty. Of course, if you were really interested in the truth you could always call UCLA and ask.

My position is that it would have been nice, and in shareholders' best interest, if they had learned from their mistakes and started the trial over in 2015. That was when they likely did the interim efficacy IA that showed major problems, and if they had been transparent with shareholders, and then taken what they learned about pseudoprogression, crossover and everything else that went awry, and started over, today we would be getting close to the release of some real, valid, and likely positive data on DCVax. But instead they didn't say anything; they just plowed ahead with a new focus on overall survival before surreptitiously changing the endpoints right before data lock, and now, almost 10 months later, who knows where we are as they scramble to salvage something, anything out of this endless trial.

What's worse is that all the while they've kept this going they've enriched themselves immensely through $500,000 salaries, the sale of Cognate, inside loans and warrant transactions, land sales, and the buildout of the Sawston operation that will be the next mega-millions jackpot to land in the CEO's bank account while not benefiting NWBO shareholders.

Dr. Liau knows what's up with this mess and I don't think she's happy about it at all.